HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.

Abstract
To determine whether the presence of anticardiolipin (aCL) antibodies in patients with acute coronary syndrome is predictive of recurrent cardiac events in hospital stay and follow-up. The study population consisted of 80 patients with acute coronary syndrome. IgM and IgG aCL levels were determined before hospital discharge. We divided the patients into those with an aCL IgG >or= 40 IgG phospholipid units (group I, n = 30) and those with an aCL IgG < 40 IgG phospholipid units (group II, n = 50). All patients underwent coronary angiography. Follow-up coronary angiography was performed 12 months after percutaneous coronary intervention (PCI). Infectious and autoimmune diseases were exclusion criteria. Patients were observed to determine overall mortality, reinfarction, and restenosis. There were no differences between the groups with respect to the prevalence of hypertension, diabetes mellitus, and cigarette smoking, sex, or ejection fraction. The prevalence of left ventricular thrombus was similar between the groups (group I: 16% versus group II: 16.7%, P > 0.05). Although the presence of left atrial thrombus was much more frequent in cardiolipin positive patients (13% versus 4%, respectively), the difference was not statistically significant (P = 0.19). Restenosis was observed in 40% of the cardiolipin positive patients and 14% of the cardiolipin negative patients (P < 0.01). There was no significant association between reinfarction and anticardiolipin positivity during follow-up (26% versus 10%, P > 0.05). In group I patients, in-hospital mortality was somewhat more frequent compared to group II patients (4% versus 10%), but the difference was not statistically significant (P = 0.27). One year mortality was similar between the groups. These results suggest that 1) restenosis occurs more frequently in anticardiolipin positive patients and 2) no association is evident between positive aCL and mortality, reinfarction, and intracardiac thrombus.
AuthorsAdalet Gürlek, Cagdaş Ozdöl, Gülgün Pamir, Irem Dinçer, Hüseyin Tutkak, Derviş Oral
JournalInternational heart journal (Int Heart J) Vol. 46 Issue 4 Pg. 631-8 (Jul 2005) ISSN: 1349-2365 [Print] Japan
PMID16157954 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Anticardiolipin
Topics
  • Aged
  • Angina, Unstable (immunology)
  • Angioplasty, Balloon, Coronary
  • Antibodies, Anticardiolipin (blood)
  • Coronary Restenosis (epidemiology, etiology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (immunology, therapy)
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Risk Factors
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: